Syme appealed to VCAT where a panel comprising a judge and two medical practitioners overruled the Medical Board. The panel declared Syme could continue to supply the rapidly acting drug copyright (generic names pentobarbital or pentobarbitone) to patients he assessed would get significant psychologi